Showing results (291-300 of 317) with videos related to
Sort By:
Pageof 32
The New England Journal of Medicine|October 23, 2014
A four-month gatifloxacin-containing regimen for treating tuberculosisCorinne S Merle, Katherine Fielding, Omou Bah Sow, et al.Lancet (London, England)|August 7, 2013
Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trialHelen Ayles, Monde Muyoyeta, Elizabeth Du Toit, et al.Implementation Science : IS|April 23, 2020
Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB)Tania F Reza, Talemwa Nalugwa, Katherine Farr, et al.Contemporary Clinical Trials Communications|May 24, 2021
Design and execution of a public randomization ceremony to enhance stakeholder engagement within a cluster randomized trial to improve tuberculosis diagnosis in UgandaTania F Reza, Talemwa Nalugwa, Mariam Nantale, et al.BMC Public Health|November 8, 2018
The effectiveness and cost-effectiveness of community-based lay distribution of HIV self-tests in increasing uptake of HIV testing among adults in rural Malawi and rural and peri-urban Zambia: protocol for STAR (self-testing for Africa) cluster randomized evaluationsMelissa Neuman, Pitchaya Indravudh, Richard Chilongosi, et al.The Journal of Infectious Diseases|March 17, 2026
Dynamics of Quantiferon-Gold Plus results in a large TB preventive treatment trial across three high-burden HIV/TB countriesBelén Saavedra-Cervera, Dinis Nguenha, Violet Chihota, et al.Internal Medicine Journal|June 20, 2017
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapseAndrew B M Lim, Cameron Curley, Chun Y Fong, et al.Ebiomedicine|June 28, 2023
IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold minersLeela R L Davies, Malisa T Smith, Deniz Cizmeci, et al.The Lancet. Microbe|July 4, 2024
Implications of subclinical tuberculosis for vaccine trial design and global effectGavin J Churchyard, Rein M G J Houben, Katherine Fielding, et al.Proceedings of the National Academy of Sciences of the United States of America|March 15, 2017
Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohortRicardo Ataide, Elizabeth A Ashley, Rosanna Powell, et al.Pageof 32